DK0846164T3 - Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease - Google Patents

Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease

Info

Publication number
DK0846164T3
DK0846164T3 DK96926574T DK96926574T DK0846164T3 DK 0846164 T3 DK0846164 T3 DK 0846164T3 DK 96926574 T DK96926574 T DK 96926574T DK 96926574 T DK96926574 T DK 96926574T DK 0846164 T3 DK0846164 T3 DK 0846164T3
Authority
DK
Denmark
Prior art keywords
protease
hcv
polypeptides
proteolytic activity
matter
Prior art date
Application number
DK96926574T
Other languages
English (en)
Inventor
Licia Tomei
Christian Steinkuehler
Antonello Pessi
Elisabetta Bianchi
Marina Taliani
Andrea Urbani
Francesco Raffaele De
Frank Narjes
Original Assignee
Angeletti P Ist Richerche Bio
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11403536&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0846164(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Angeletti P Ist Richerche Bio filed Critical Angeletti P Ist Richerche Bio
Application granted granted Critical
Publication of DK0846164T3 publication Critical patent/DK0846164T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/503—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses
    • C12N9/506—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from viruses derived from RNA viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DK96926574T 1995-08-22 1996-08-20 Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease DK0846164T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT95RM000573A IT1277914B1 (it) 1995-08-22 1995-08-22 Procedimento per produrre - in forma pura e in quantita' elevate - polipeptidi con l'attivita' proteolitica della proteasi ns3 di hcv, e
PCT/IT1996/000163 WO1997008304A2 (en) 1995-08-22 1996-08-20 Methodology to produce, purify and assay polypeptides with the proteolytic activity of the hcv ns3 protease
EP96926574A EP0846164B1 (en) 1995-08-22 1996-08-20 Method for assaying in vitro the proteolytic activity of polypeptides having hcv ns3 protease activity and peptide substrates to be used in this method.

Publications (1)

Publication Number Publication Date
DK0846164T3 true DK0846164T3 (da) 2005-06-27

Family

ID=11403536

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96926574T DK0846164T3 (da) 1995-08-22 1996-08-20 Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease

Country Status (14)

Country Link
US (1) US6197536B1 (da)
EP (1) EP0846164B1 (da)
JP (1) JP3310298B2 (da)
CN (1) CN1193997A (da)
AT (1) ATE290070T1 (da)
AU (1) AU716379B2 (da)
BR (1) BR9610039A (da)
CA (1) CA2228265C (da)
DE (1) DE69634406T2 (da)
DK (1) DK0846164T3 (da)
ES (1) ES2236743T3 (da)
IT (1) IT1277914B1 (da)
PT (1) PT846164E (da)
WO (1) WO1997008304A2 (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1285158B1 (it) * 1996-09-17 1998-06-03 Angeletti P Ist Richerche Bio Polipeptidi solubili con l'attivita' di serino-proteasi di ns3 del virus dell'epatite c, e procedimento per la loro preparazione e il
GB9623908D0 (en) * 1996-11-18 1997-01-08 Hoffmann La Roche Amino acid derivatives
GB9707659D0 (en) * 1997-04-16 1997-06-04 Peptide Therapeutics Ltd Hepatitis C NS3 Protease inhibitors
ES2143918B1 (es) * 1997-05-23 2001-01-01 Inst Cientifico Tecnol Navarra Peptidos inhibidores de la proteasa c y su utilizacion en la preparacion de composiciones utiles en las infecciones causadas por el virus de la hepatitis c.
US6211338B1 (en) 1997-11-28 2001-04-03 Schering Corporation Single-chain recombinant complexes of hepatitis C virus NS3 protease and NS4A cofactor peptide
IT1299134B1 (it) * 1998-02-02 2000-02-29 Angeletti P Ist Richerche Bio Procedimento per la produzione di peptidi con proprieta' inibitrici della proteasi ns3 del virus hcv, peptidi cosi' ottenibili e peptidi
WO2000001718A2 (en) * 1998-07-02 2000-01-13 University Of Florida Ns4a-ns3 catalytic domain of hepatitis c
US6323180B1 (en) * 1998-08-10 2001-11-27 Boehringer Ingelheim (Canada) Ltd Hepatitis C inhibitor tri-peptides
EP1141255A4 (en) 1999-01-08 2002-09-11 Bristol Myers Squibb Co MODIFIED FORMS OF HEPATITIS C VIRUS NS3 PROTEASE
MXPA01011045A (es) * 1999-05-04 2002-07-22 Boehringer Ingelheim Ltd Sistema sustituto basado en celulas y metodo para evaluar la actividad de la proteasa ns3 de virus de la hepatitis c.
WO2001016379A1 (en) * 1999-08-30 2001-03-08 Merck & Co., Inc. Hepatitis c virus replication inhibitors
GB0006537D0 (en) * 2000-03-17 2000-05-10 Angeletti P Ist Richerche Bio Assays and screening methods
HUP0302558A3 (en) 2000-12-15 2012-03-28 Boehringer Ingelheim Ca Ltd Purified active hcv ns2/3 protease
MXPA05004276A (es) * 2002-10-29 2005-08-03 Boehringer Ingelheim Int Ns3 de proteasa de hcv resistente a inhibidor.
WO2006102087A2 (en) * 2005-03-22 2006-09-28 Merck & Co., Inc. Hcv protease substrates
EP1945797B1 (en) * 2005-10-28 2012-05-30 Boehringer Ingelheim International GmbH Hepatitis c virus ns2/3 activity assay
CN103012565B (zh) * 2013-01-15 2014-07-16 成都天台山制药有限公司 一种曲普瑞林及其固相合成制备方法
JP6564539B1 (ja) * 2018-09-14 2019-08-21 長瀬産業株式会社 スルホン酸化合物によるペプチド精製方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE433460T1 (de) * 1990-04-04 2009-06-15 Novartis Vaccines & Diagnostic Protease von hepatitis c virus
EP0729973A4 (en) * 1993-10-29 1998-12-30 Srl Inc AN ANTIQUE PEPTIDE COMPOUND AND IMMUNOASSAY PROCEDURE
JPH08205893A (ja) * 1994-12-08 1996-08-13 Sumitomo Metal Ind Ltd Ｈｃｖプロテアーゼ活性測定法
US5767233A (en) * 1995-05-12 1998-06-16 Schering Corporation Soluble cleavable substrates of the hepatitis C virus protease

Also Published As

Publication number Publication date
ITRM950573A1 (it) 1997-02-22
ES2236743T3 (es) 2005-07-16
US6197536B1 (en) 2001-03-06
PT846164E (pt) 2005-07-29
CN1193997A (zh) 1998-09-23
ITRM950573A0 (it) 1995-08-22
ATE290070T1 (de) 2005-03-15
BR9610039A (pt) 1999-07-06
AU6668696A (en) 1997-03-19
JP3310298B2 (ja) 2002-08-05
JPH10511556A (ja) 1998-11-10
DE69634406D1 (de) 2005-04-07
EP0846164B1 (en) 2005-03-02
IT1277914B1 (it) 1997-11-12
WO1997008304A3 (en) 1997-05-22
WO1997008304A2 (en) 1997-03-06
CA2228265C (en) 2002-08-13
DE69634406T2 (de) 2006-04-13
EP0846164A2 (en) 1998-06-10
AU716379B2 (en) 2000-02-24
CA2228265A1 (en) 1997-03-06

Similar Documents

Publication Publication Date Title
DK0846164T3 (da) Metodologi til fremstilling, oprensning og assay af polypeptider med den proteolytiske aktivitet af HCV NS3-protease
Várallyay et al. Two mutations in rat trypsin confer resistance against autolysis
Dang et al. Residue 225 determines the Na (+)-induced allosteric regulation of catalytic activity in serine proteases.
Smith et al. Bovine liver glutamate dehydrogenase: tentative amino acid sequence; identification of a reactive lysine; nitration of a specific tyrosine and loss of allosteric inhibition by guanosine triphosphate
Yaron et al. Proline-dependent structural and biological properties of peptides and proteins
CA2182521A1 (en) Method for Reproducing in Vitro the Proteolytic Activity of the NS3 Protease of Hepatitis C Virus (HCV)
Stoecker et al. Fluorescent oligopeptide substrates for kinetic characterization of the specificity of Astacus protease
RU96119350A (ru) Способ репродукции in vitro протеолитической активности ns3 протеазы вируса гепатита c(нсу)
FI950042A (fi) Menetelmä entsyymin immobilisoimiseksi mikrobisolun soluseinämään valmistamalla fuusioproteiini
JPH09510363A (ja) 非タンパク質プロテアーゼ抑制剤を使用するプロテアーゼ酵素の製造
JPH11501814A (ja) 減少した吸着性と増加した加水分解性を有するプロテイナーゼｋ変種
WO1990003435A3 (fr) Acide nucleique codant pour l'enzyme de conversion de l'angiotensine (eca) humaine, et ses applications, notamment pour le diagnostic in vitro de l'hypertension arterielle
Louis et al. Chemical synthesis and expression of the HIV-1 protease gene in E. coli
Ortiz et al. Diastereotopic covalent binding of the natural inhibitor leupeptin to trypsin: detection of two interconverting hemiacetals by solution and solid-state NMR spectroscopy
DE69418035D1 (de) Hiv-proteaseinhibitoren
Smith et al. The evolution of proteinase substrates with special reference to dipeptidylpeptidase IV
Suhrbier et al. BLT esterase activity as an alternative to chromium release in cytotoxic T cell assays
Hiltkel et al. Structure/function analysis of human cystatin SN and comparison of the cysteine proteinase inhibitory profiles of human cystatins C and SN
Kim et al. Catalytic role of a surface loop of the complement serine protease factor D.
Korant Role of cellular and viral proteases in the processing of picornavirus proteins
Tang et al. Understanding HIV protease: can it be translated into effective therapy against AIDS?
Matsuda et al. Proteolytic activity against model peptides of the cell wall lytic enzyme from Chlamydomonas
Turner et al. Pharmacology of enkephalinase inhibitors
Gardner et al. N-terminal fragments of CCK-(26-33) as cholecystokinin receptor antagonists in guinea pig pancreatic acini
Rockwell et al. Synthesis of peptidyl methylcoumarin esters as substrates and active-site titrants for the prohormone processing proteases Kex2 and PC2